Analgesics in Sweden

October 2024 | | ID: A9CE65D3C2CEN
Euromonitor International Ltd

Abstracts

Analgesics is a key product area within consumer health in Sweden, accounting for over one-fifth of overall OTC value sales in 2024. The category witnessed moderate current value growth in 2024 as concerns regarding the economy abated and inflation decreased significantly. The consumption of analgesics has returned to normal levels following the strong growth seen during the pandemic. Retail volume sales of adult analgesics have returned to growth following the declines seen in 2023.

Euromonitor International's Analgesics in Sweden report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Analgesics market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

Analgesics in Sweden
Euromonitor International
October 2024

LIST OF CONTENTS AND TABLES

ANALGESICS IN SWEDEN
KEY DATA FINDINGS

2024 DEVELOPMENTS

Rebound in demand drives moderate growth of analgesics
Acetaminophen is the preferred analgesic among Swedes
Retail e-commerce attracts consumers seeking lower prices and shopping convenience
PROSPECTS AND OPPORTUNITIES
Holistic approach to wellness and maturity will limit growth prospects
Pharmacies to remain top of the distribution landscape
Topical analgesics faces muted growth
CATEGORY DATA
Table 1 Sales of Analgesics by Category: Value 2019-2024
Table 2 Sales of Analgesics by Category: % Value Growth 2019-2024
Table 3 NBO Company Shares of Analgesics: % Value 2020-2024
Table 4 LBN Brand Shares of Analgesics: % Value 2021-2024
Table 5 Forecast Sales of Analgesics by Category: Value 2024-2029
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2024-2029
CONSUMER HEALTH IN SWEDEN
EXECUTIVE SUMMARY
Consumer health in 2024: The big picture

2024 KEY TRENDS

Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2019-2024
Table 8 Life Expectancy at Birth 2019-2024
MARKET DATA
Table 9 Sales of Consumer Health by Category: Value 2019-2024
Table 10 Sales of Consumer Health by Category: % Value Growth 2019-2024
Table 11 NBO Company Shares of Consumer Health: % Value 2020-2024
Table 12 LBN Brand Shares of Consumer Health: % Value 2021-2024
Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2019-2024
Table 14 Distribution of Consumer Health by Format: % Value 2019-2024
Table 15 Distribution of Consumer Health by Format and Category: % Value 2024
Table 16 Forecast Sales of Consumer Health by Category: Value 2024-2029
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2024-2029
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources